Phase 2 Progressive Multiple Sclerosis trials recruiting now

All Progressive Multiple Sclerosis trials, every phase

Phase 2 Progressive Multiple Sclerosis trials

• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
  NCT07282574 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 108 locations
• Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis
  NCT05740722 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
  NCT06675864 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 18 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.